triamterene has been researched along with Acquired Nephrogenic Diabetes Insipidus in 1 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Excerpt | Relevance | Reference |
|---|---|---|
| " After improvement in hypercalcemia and unsuccessful indapamide treatment, triamterene was administrated to control polyuria." | 4.02 | Triamterene in lithium-induced nephrogenic diabetes insipidus: a case report. ( Inoue, M; Mitsuiki, K; Nakai, K, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, M | 1 |
| Nakai, K | 1 |
| Mitsuiki, K | 1 |
1 other study available for triamterene and Acquired Nephrogenic Diabetes Insipidus
| Article | Year |
|---|---|
Triamterene in lithium-induced nephrogenic diabetes insipidus: a case report.
Topics: Administration, Cutaneous; Aged, 80 and over; Bipolar Disorder; Central Nervous System Depressants; | 2021 |